Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
J.H. Cohn was a prominent American accounting and consulting firm that merged with Reznick Group in 2012 to form CohnReznick. The firm maintained a significant Life Sciences practice, providing specialized audit, tax, and advisory services to biotechnology, pharmaceutical, and medical device companies. Their expertise included assisting life science entities with R&D tax credits, revenue recognition, and navigating the complexities of clinical trial accounting. As a service provider, the firm supported companies from early-stage research through commercialization and IPO. The firm was particularly active in the Northeast United States, a major hub for the pharmaceutical and biotech industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on J.H. Cohn.